Recordati Industria Chimica e Farmaceutica S.p.A. Financials

Market Capitalization €11.32 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.18
Forward PE	19.82
Price to Sales TTM	€4.99
Price to Book MRQ	€6.04
Enterprise to Revenue	5.55
Enterprise to EBITDA	15.04

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	18.65%
Operating Margin	30.57%
Return on Assets TTM	10.35%
Return on Equity TTM	23.50%

Income Statement

Revenue TTM	€2,269,238,016
Revenue per Share TTM	€11.01
Quarterly Revenue Growth	8.90%
Gross Profit TTM	€1,602,802,048
EBITDA	€799,466,000
Net Income to Common TTM	€423,121,984
Diluted EPS TTM	€2.02
Quarterly Earnings Growth YoY	46.90%

Balance Sheet

Total Cash MRQ	€235,020,000
Total Cash per Share MRQ	€1.14
Total Debt MRQ	€
Total Debt to Equity MRQ	83.78
Current Ratio MRQ	1.39
Book Value per Share MRQ	€9.10

Cash Flow

Operating Cash Flow TTM	€530,404,000
Levered Free Cash Flow TTM	€502,028,000

REC Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	206,275,008
Float Shares	96,943,573
Avg 10 Volume	295,406
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.80%
% Held by Institutions	27.22%

Stock Price Summary

Beta	0.40
Fifty Two Week Low	€47.28
Fifty Two Week High	€56.30
Fifty Two Week Change	9.57%
Day 50 MA	€51.50
Day 200 MA	€50.81

Dividends and Splits

Forward Annual Dividend Rate	€1.20
Forward Annual Dividend Yield	2.14%
Trailing Annual Dividend Rate	€1.23
Trailing Annual Dividend Yield	2.20%
Payout Ratio	59.32%
Dividend Date
Ex Dividend Date	2024-11-18
Last Split Factor
Last Split Date	2005-04-18